Advertisement
News
Advertisement

Immunogen stock jumps on analyst report

Wed, 08/22/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Immunogen Inc. (Nasdaq: IMGN) saw its stock rise almost 4 percent Wednesday, after an analyst at New York investment bank Cowen and Co. launched coverage of the stock with an “outperform” or “buy” rating.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading